Clinical Trial

A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a retrospective real-world study. In this study, we plan to collect the clinical data of lung metastatic nasopharyngeal carcinoma patients who received PD-1 inhibitors and chemotherapy combined with or without radiotherapy.
Trial Details
NCT Number NCT07062484
Lead Sponsor Sichuan Cancer Hospital and Research Institute
Conditions Lung Metastatic Nasopharyngeal Carcinoma
Enrollment 600 participants
Start Date 2025-07
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-14